Connect Biopharma Holdings (CNTB) Total Current Liabilities (2023 - 2025)
Historic Total Current Liabilities for Connect Biopharma Holdings (CNTB) over the last 3 years, with Q3 2025 value amounting to $11.4 million.
- Connect Biopharma Holdings' Total Current Liabilities changed N/A to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year change of. This contributed to the annual value of $8.5 million for FY2024, which is 6654.41% down from last year.
- According to the latest figures from Q3 2025, Connect Biopharma Holdings' Total Current Liabilities is $11.4 million.
- In the past 5 years, Connect Biopharma Holdings' Total Current Liabilities ranged from a high of $25.3 million in Q4 2023 and a low of $8.5 million during Q4 2024
- Moreover, its 3-year median value for Total Current Liabilities was $10.7 million (2025), whereas its average is $12.7 million.
- Per our database at Business Quant, Connect Biopharma Holdings' Total Current Liabilities plummeted by 6654.41% in 2024 and then surged by 1160.64% in 2025.
- Connect Biopharma Holdings' Total Current Liabilities (Quarter) stood at $25.3 million in 2023, then plummeted by 66.54% to $8.5 million in 2024, then skyrocketed by 35.04% to $11.4 million in 2025.
- Its last three reported values are $11.4 million in Q3 2025, $10.7 million for Q2 2025, and $8.6 million during Q1 2025.